Another area to consider is lymphoedema because loss‐of‐function mutations in PIEZO1 are associated with generalised lymphatic dysplasia (Fotiou et al., 2015), and so PIEZO1 agonists might be beneficial if partly functional channels are still available. The gene discussed is PIEZO1; the disease is lymphedema.